- Home
- SRBK vs MBOT Comparison
SRBK vs MBOT Comparison
Compare SRBK & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$2.11
Company Overview
Basic Information| Metric | SRBK | MBOT |
|---|---|---|
| Founded | 1887 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 123.7M | 134.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SRBK | MBOT |
|---|---|---|
| Price | $15.92 | $2.11 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $8.75 |
| AVG Volume (30 Days) | 38.2K | ★ 1.5M |
| Earning Date | 01-30-2026 | 11-12-2025 |
| Dividend Yield | ★ 1.27% | N/A |
| EPS Growth | ★ 374.69 | N/A |
| EPS | ★ 0.54 | N/A |
| Revenue | ★ $31,130,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3,119.61 |
| P/E Ratio | $29.09 | ★ N/A |
| Revenue Growth | ★ 0.85 | N/A |
| 52 Week Low | $11.36 | $1.25 |
| 52 Week High | $17.11 | $4.67 |
Technical Indicators
Market Signals| Indicator | SRBK | MBOT |
|---|---|---|
| Relative Strength Index (RSI) | 50.11 | 45.96 |
| Support Level | $15.65 | $2.05 |
| Resistance Level | $16.10 | $2.15 |
| Average True Range (ATR) | 0.36 | 0.11 |
| MACD | -0.11 | -0.00 |
| Stochastic Oscillator | 24.43 | 48.45 |
Price Performance
Historical Comparison SRBK
MBOT
About SRBK SR Bancorp Inc.
SR Bancorp Inc principal business is to acquire deposits from individuals and businesses in the communities surrounding offices and to use these deposits to fund loans.
About MBOT Microbot Medical Inc.
Microbot Medical Inc is a breakthrough medical device company. The group is focused on transforming endovascular procedures through advanced robotic technology. Microbot's LIBERTY Endovascular Robotic System is the first single-use, remotely operated robotic solution designed for precision, efficiency and provider safety. With a robust intellectual property portfolio and a deep commitment to innovation, Microbot is shaping the future of endovascular care.